Author:
Zbar A. P.,Thomas H.,Wilkinson R. W.,Wadhwa M.,Syrigos K. N.,Ross E. L.,Dilger P.,Allen-Mersh T. G.,Kmiot W. A.,Epenetos A. A.,Snary D.,Bodmer W. F.
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Mellstedt H (2003) Monoclonal antibodies in human cancer. Drugs Today (Barc) 39 [Suppl]:C1–C16
2. Mellstedt H, Frodin J-E, Masucci G, Ragnhammar, Fagerberg J, Hjelm AL, Shetye J, Wersall P, Osterborg A (1991) The therapeutic use of monoclonal antibodies in colorectal carcinoma. Semin Oncol 18:462–477
3. Riethmuller G, Schneider-Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Pichlmaier H, Hirsch R, Pichlmayr R et al (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes’ C colorectal carcinoma. Lancet 343:1177–1183
4. Riethmuller G, Holz E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Funke I, Pichlmaier H, Hirche H, Buggisch P, Witte J, Pichlmayr R (1998) Monoclonal antibody therapy for resected Dukes’ C colorectal cancer: seven year outcome of a multicenter randomized trial. J Clin Oncol 16:1788–1794
5. Punt CJA, Nagy A, Douillard JY et al (2001) Edrecolomab (17-1A antibody) alone or in combination with 5-fluorouracil based chemotherapy in the adjuvant treatment of stage III colon cancer: results of a phase III study. Proc Am Soc Clin Oncol 20:123(A)
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献